KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Biogen (BIIB) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Biogen (BIIB) over the last 14 years, with Q4 2022 value amounting to $167.9 million.

  • Biogen's Shares Outstanding fell 169.79% to $167.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $167.9 million, marking a year-over-year decrease of 169.79%. This contributed to the annual value of $167.9 million for FY2022, which is 169.79% down from last year.
  • Latest data reveals that Biogen reported Shares Outstanding of $167.9 million as of Q4 2022, which was down 169.79% from $170.8 million recorded in Q4 2021.
  • Biogen's Shares Outstanding's 5-year high stood at $225.2 million during Q2 2018, with a 5-year trough of $167.9 million in Q4 2022.
  • For the 5-year period, Biogen's Shares Outstanding averaged around $201.6 million, with its median value being $207.2 million (2019).
  • Per our database at Business Quant, Biogen's Shares Outstanding surged by 379.15% in 2019 and then plummeted by 1273.97% in 2020.
  • Biogen's Shares Outstanding (Quarter) stood at $221.0 million in 2018, then decreased by 10.41% to $198.0 million in 2019, then dropped by 11.01% to $176.2 million in 2020, then dropped by 3.06% to $170.8 million in 2021, then decreased by 1.7% to $167.9 million in 2022.
  • Its last three reported values are $167.9 million in Q4 2022, $170.8 million for Q4 2021, and $176.2 million during Q4 2020.